TBX1 and neoplasm: For instance, a preclinical study demonstrated the efficacy of saridegib, a Smoothened (SMO) inhibitor pivotal for the hedgehog pathway, in diminishing stromal compartments within tumors and increasing the density of blood vessels within the tumor core by targeting CAFs.